Advanced tech company, PhaseV, has raised $15 million in fun

Advanced tech company, PhaseV, has raised $15 million in funding that it says it will use to ‘push the boundaries of machine learning for clinical trial optimization’.

Related Keywords

Zvika Orron , Miriam Kidron , Raviv Pryluk , Noam Ohana , Deloitte , Oramed Pharmaceuticals Inc , Viola Ventures , Exor Ventures , Pharmaceuticals Inc , Markets Amp Regulations , Funding , Investment , Machine Learning , Research , Clinical Trial , Ptimization ,